PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of frontmicrobioLink to Publisher's site
 
Front Microbiol. 2013; 4: 310.
Published online 2013 October 17. doi:  10.3389/fmicb.2013.00310
PMCID: PMC3797959

Protein-linked glycans in periodontal bacteria: prevalence and role at the immune interface

Abstract

Protein modification with complex glycans is increasingly being recognized in many pathogenic and non-pathogenic bacteria, and is now thought to be central to the successful life-style of those species in their respective hosts. This review aims to convey current knowledge on the extent of protein glycosylation in periodontal pathogenic bacteria and its role in the modulation of the host immune responses. The available data show that surface glycans of periodontal bacteria orchestrate dendritic cell cytokine responses to drive T cell immunity in ways that facilitate bacterial persistence in the host and induce periodontal inflammation. In addition, surface glycans may help certain periodontal bacteria protect against serum complement attack or help them escape immune detection through glycomimicry. In this review we will focus mainly on the generalized surface-layer protein glycosylation system of the periodontal pathogen Tannerella forsythia in shaping innate and adaptive host immunity in the context of periodontal disease. In addition, we will also review the current state of knowledge of surface protein glycosylation and its potential for immune modulation in other periodontal pathogens.

Keywords: protein glycosylation, periodontal bacteria, immune response

INTRODUCTION

Until relatively recently, protein glycosylation was believed to be restricted only to eukaryotic proteins. However, with the availability of genome-scale information and sophisticated mass spectrometry as well as nuclear magnetic resonance techniques primarily from the past decade it has come to light that protein glycosylation occurs quite frequently in bacteria as well (Nothaft and Szymanski, 2010). More and more bacterial proteins of Gram-positive and Gram-negative origin are frequently being identified with N- and O-linked glycan modifications (Ashline et al., 2005; Brisson et al., 2010; reviewed in Iwashkiw et al., 2012, 2013). Moreover, it is becoming apparent that protein glycosylation is also prevalent amongst Archaea (Eichler, 2013; Kandiba and Eichler, 2013). Dedicated computational algorithms have also been developed to predict glycosylated residues in prokaryotic proteins (Chauhan et al., 2012), and a web program, GlycoPP at http://www.imtech.res.in/raghava/glycopp/index.html, using such algorithms is currently available for predicting N- and O-glycosylation sites in prokaryotic protein sequences with an accuracy of 70–80%. In most cases bacterial glycans are linked directly to asparagine or serine/threonine residues within specific peptide motifs for N- and O-glycosylation, respectively. Proteins such as flagellins, pilins, and surface (S)-layer proteins have been shown to be glycosylated quite extensively in bacteria by dedicated glycosylation systems (Nothaft and Szymanski, 2010). Recent studies have alluded to the role of protein glycosylation in immune modulation in pathogenic as well as commensal bacteria, such as in Neisseria species (Vik et al., 2009), Campylobacter jejuni (Szymanski and Wren, 2005), and Bacteroides fragilis (Fletcher et al., 2009), and in attachment and infective ability of Chlamydia trachomatis (Kuo et al., 1996) and C. jejuni species (Szymanski et al., 2002; Karlyshev et al., 2004). In addition, variations in flagellar protein-linked glycans in C. jejuni have been shown to cause phenotypic phase-variations and antigenic diversity, important for the pathogen’s virulence (Guerry et al., 2006; Young et al., 2007; Hitchen et al., 2010).

With respect to the human oral cavity, the niche is colonized with nearly 700 bacterial species with different taxa and phylotypes (Dewhirst et al., 2010). Of these diverse bacteria, a select group of Gram-negative anaerobes residing in the subgingival crevices (spaces between the teeth and gums; Figure Figure11) as biofilms induce one of the most common forms of the inflammatory disease in humans, known as periodontitis. This disease is characterized by the progressive destruction of the tooth supporting apparatus and often leads to tooth loss in adults. In addition, chronic infections with periodontal pathogens have been linked to the risk for systemic health conditions such as cardiovascular, diabetic, respiratory, and arthritic diseases (Beck et al., 2008; Genco, 2009; Gomes-Filho et al., 2009; Genco and Van Dyke, 2010; Scher et al., 2012). A group of bacteria known as the “red complex” comprising Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia has been strongly implicated in the initiation and progression of periodontitis (Socransky et al., 1998). We discuss below recent data mainly from studies in T. forsythia and P. gingivalis that suggest these bacteria utilize protein glycosylation for undermining the host immunity to persist in the host and cause periodontal destruction.

FIGURE 1
chematic representation of the periodontal tissues supporting the tooth. A histological section of the gingival tissue stained with toluidine blue is shown on the right (courtesy, Dr. Moon-Il Cho, University at Buffalo).

PROTEIN-LINKED GLYCANS OF PERIODONTAL BACTERIA AS IMMUNOMODULATORS

The periodontal pathogen T. forsythia possesses a S-layer, a tooth-like serrated layer covering the outer-membrane (Sabet et al., 2003; Figure Figure2A2A). S-layers are comprised of water insoluble proteins intrinsically capable of self-assembling into crystalline lattice and are believed to provide protection against the deleterious effects of the environment as well host immune components (Sara and Sleytr, 2000). S-layer proteins in Gram-positive bacteria may be glycosylated by the addition of O-linked long-chain glycan repeats in a process similar to lipopolysaccharide (LPS) biosynthesis (Messner et al., 2008). The T. forsythia S-layer, however, is unique in that it is the only Gram-negative S-layer known to date which is glycosylated (Lee et al., 2006). It is comprised of two high molecular weight glycoproteins, TfsA (200 kDa) and TfsB (210 kDa) which are clearly prominent in the protein profiles of this organism and make up a large proportion of the total bacterial protein.

FIGURE 2
(A) Transmission electron microscopy (TEM) micrographs of T. forsythia ultrathin sections. (B) Schematic diagram of the O-glycan core structure linked to a peptide motif in Tannerella surface-layer proteins. A terminal trisaccharide motif synthesized ...

Our previous work and that of the Schaffer group (using our wecC mutant) showed that a putative exopolysaccharide synthesis operon wecC-neuC-gtf is involved in the O-glycosylation of Tannerella S-layer and other surface proteins (Honma et al., 2007; Posch et al., 2011). Specifically, the wecC gene product (UDP-N-acetylmannosaminuronic acid dehydrogenase homolog) was shown to be involved in the addition of a three-sugar-branch motif comprising two sub-terminal mannosuronic acid (ManNAcA) and a terminal modified pseudaminic acid residues (Pse5Am7Gc, 5-acetimidol-7-N-glycolyl-pseudaminic acid) on an O-linked oligosaccharide core attached to the surface glycoproteins (Posch et al., 2011; Figure Figure2B2B). The glycan core is attached to the S-layer protein (and several other Tannerella surface proteins) at several sites in each protein via O-linkages at Ser, Thr, or Tyr residues within the three amino acid motif D(S,T)(A,L,V,I,M,T) (Posch et al., 2011). This mode of glycosylation at specific three amino acid motifs appears to be well conserved across a range of Bacteroidetes species. This is evidenced by elegant transcomplementation experiments in which the T. forsythia S-layer protein was produced and glycosylated at this motif with the B. fragilis specific glycan, and vice versa, i.e., a B. fragilis protein was glycosylated in T. forsythia with the Tannerella glycan (Posch et al., 2013). In fact this has now been shown to be the case in a range of Bacteroides, Prevotella, and Porphyromonas species with bioinformatic (Fletcher et al., 2011) as well as experimental approaches using an antibody against the core component of the Bacteroides group O-glycan (Coyne et al., 2013). This conservation of a general O-glycosylation system in Bacteroidetes is indicative of its potentially essential function in divergent Bacteroidetes species living in wide-ranging niches.

Previous studies have shown that the Tannerella S-layer is capable of mediating bacterial attachment to and invasion of epithelial cells (Lee et al., 2006). Furthermore, for the benefit of the bacterium, the S-layer helps to blocks the early release of inflammatory cytokines by immune cells. The role of S-layer glycosylation on the bacterium’s ability to directly modulate host immunity to impact its in vivo life-cycle has now come to light. A recent study from our laboratory showed that loss of the terminal trisaccharide branch motif on the S-layer as well as a number of other O-glycosylated surface proteins due to wecC deficiency renders the bacterium increasingly prone to recognition and processing by antigen-presenting cells (Settem et al., 2012). Specifically, the loss of this terminal tri-saccharide branch (Figure Figure2B2B) promotes phagocytosis of the bacterium by a subset of antigen presenting cells called dendritic cells (DCs) and concurrent induction of Th17-activating cytokines IL-6 and IL-23 (Settem et al., 2012). This modulation of DC responses has major consequences for pathogenesis since DCs reside as immune system sentinels within tissues that constantly encounter invading microbes. In tissues they recognize different pathogen-associated molecular patterns (PAMPs) and act to direct innate and adaptive immune responses locally via pathogen-recognition receptors (PRRs), a group of molecules which include Toll-like receptors (TLRs), nucleotide oligomerization domain receptors (NODs), and C-type lectin-like receptors (CLRs; Takeuchi and Akira, 2010). It is the latter of these, the CLRs, which are most pertinent to the recognition of bacterial O-glycans since their function is to act as carbohydrate binding receptors. Thus, surface O-linked glycans, the tri-saccharide motif in particular, impact DC-mediated processing of the bacterium, also impacting the activation of intracellular receptors and inflammasome processing for IL-23 induction. This manipulation of DC behavior via carbohydrate ligands is a growing theme in bacterial pathogen biology and several recent studies indicate that bacterial polysaccharides can block recognition and phagocytosis of microbes by DCs and macrophages (Meijerink et al., 2012). Moreover, microbe-associated glycans regulate DC maturation and cytokine secretion to affect polarization of naïve T cells into specific subtypes upon microbial infection, with signaling crosstalk between CLRs and TLRs thought to influence this development (Geijtenbeek and Gringhuis, 2009). In the case of T. forsythia, O-glycan-mediated signaling via a CLR might synergize with TLR2-dependent signaling induced by the bacterium’s major virulence factor and TLR2 ligand, the BspA protein (Onishi et al., 2008; Myneni et al., 2012; Figure Figure2C2C).

Indeed, in line with the above predictions, the terminal O-glycan motif attached to the surface proteins of T. forsythia does seem to be a key factor in influencing T cell polarization during T. forsythia infection. The evidence to support this comes from data generated in mouse models infected with wild-type bacteria (decorated with the O-glycan) which induce robust TLR2-dependent Th2-biased inflammatory responses, leading to alveolar bone resorption (Myneni et al., 2011). Strikingly, this TLR2-Th2 bias is perturbed in response to infection with a bacterial strain lacking the terminal tri-saccharide O-glycan (i.e., a wecC mutant, Figure Figure2B2B) and when mice are infected with the strain lacking this terminal three-sugar branch motif on the O-linked glycan core, T cells polarize into the Th17 subset (Settem et al., 2012). This leads to increased infiltration of neutrophils into the gingival tissues and therefore decreased persistence of bacteria in periodontal tissues, resulting in reduced alveolar bone loss compared to the mice infected with the wild-type strain (Settem et al., 2012). Taken together, these data suggest that the surface O-glycan motif of T. forsythia is involved in suppressing Th17 responses, which allow increased bacterial persistence, promoting Th2-dependent inflammatory alveolar bone destruction (Figure Figure2C2C).

The other “red complex” periodontal pathogen P. gingivalis possesses two types of cell-surface fimbriae, the major fimbria known as FimA and the minor fimbria known as Mfa1. Mfa1 is comprised of a 67-kDa protein with N- and O-linked fucose, mannose, N-acetylglucosamine, and N-acetylgalactosamine sugars (Zeituni et al., 2010). Mfa1 activates DC-SIGN (dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin) lectin on DCs. On the other hand, the 43-kDa major fimbrial protein FimA is non-glycosylated and activates TLR2. Recent studies further suggest that a crosstalk between TLR2 and DC-SIGN signaling due to FimA and Mfa1 fimbria, respectively, modulates the expression of Th cell differentiation cytokines in DCs against P. gingivalis, and is thus thought to orchestrate specific T cell immunity (Zeituni et al., 2010).

Orchestration of Th bias through the mediation of glycan modifications is not confined to periodontal pathogens alone, but is widely observed in the gastrointestinal pathogens and commensals. In the case of C. jejuni, surface capsular polysaccharide modifications with methyl phosphoramidate have been shown to modulate Th17 immunity against the pathogen and thus impact bacterial persistence in the host (Maue et al., 2012). With respect to the ubiquitous commensal and opportunistic pathogen – B. fragilis, the expression of its polysaccharide antigen (PSA) helps to keep inflammatory T cell lineages (e.g., Th17) in check and simultaneously promote IL-10-producing FoxP3(+) Treg cells in the gut (Mazmanian et al., 2008; Ochoa-Reparaz et al., 2010; Surana and Kasper, 2012). This role of PSA in influencing T cell populations is so profound that PSA-deficient bacteria skew the balance so far toward Th17 cells that infected mice develop colitis. Similar types of zwitterionic polysaccharides (ZPS) with immunomodulatory roles have also been identified in bacteria such as Streptococcus pneumoniae and Staphylococcus aureus type-5 and -8 (Tzianabos et al., 2000; Gonzalez-Fernandez et al., 2008). A clear mechanistic understanding of how bacterial polysaccharide regulate T cell polarization is lacking in light of the fact that PSAs are generally not presented to T cells (T cell independent) via antigen presenting cells. Rather, it has been demonstrated that ZPS antigens can be presented to T cells by APCs in an major histocompatibility complex class II (MHC-II) restricted manner (Avci and Kasper, 2010). This picture is further complicated by evidence suggesting that many oligosaccharides linked to peptides can directly activate T cells (Avci et al., 2013). Whether or not Tannerella polysaccharides are recognized by MHC-II or directly activate T cells is currently unknown. Alternatively, modulation of DCs through activation of CLRs such as DC-SIGN by Tannerella glycans could plausibly regulate the secretion of T cell biasing cytokines. In support of this notion, DC-SIGN is known to exhibit crosstalk with TLRs and impact the maturation of DCs and differentially regulate the cytokine environment, promoting polarization of T cells into specific subsets (Geijtenbeek and Gringhuis, 2009; Geijtenbeek et al., 2009; van den Berg et al., 2012).

OTHER GLYCAN-RELATED FACTORS OF PERIODONTAL BACTERIA

It is also worth noting that several glycoproteins with potential roles in bacterial pathogenicity, including the arginine- (RgpB and RgpA) and lysine-specific (Kgp) cysteine proteinases (collectively known as gingipains) and major outer-membrane protein pgm6 (OmpA) have been reported in P. gingivalis (Kishi et al., 2012). Gingipain proteases are major virulence factors of P. gingivalis that paralyze host immune defenses by degrading serum complement, antibodies and chemokines, and T cell biasing cytokines (Guo et al., 2010). Although glycans linked to gingipains per se do not play any direct role in corrupting host defense molecules, post-translation polysaccharide modifications via a novel protein secretion system (PorSS; Paramonov et al., 2005; Glew et al., 2012) as well as a Vim (virulence modulating) dependent glycosylation system (Aruni et al., 2013) play an essential role in the biogenesis of these proteases in P. gingivalis. In addition, recent work of Comstock and colleagues on the general O-glycosylation system in Bacteroidales species suggests the presence of a shared O-glycosylation system in a range of periodontal pathogens including P. gingivalis and at least two Prevotella spp. (Coyne et al., 2013). With respect to another major periodontal pathogen, Treponema denticola, a recent study points to the role of sialic acid modified surface glycoproteins in resisting the serum complement mediated killing of the pathogen (Kurniyati et al., 2013). However, basic information regarding the glycosylation machinery in this important pathogen is currently lacking. It is also worth noting that many species of Campylobacter associated with periodontitis (Macuch and Tanner, 2000), namely, C. rectus, C. showae, and C. concisus appear to also possess possible flagella glycosylation islands based on genome predictions (unpublished).

Furthermore, most intriguing is the presence of myriad glycosidases in the periodontal pathogen T. forsythia (Sharma, 2010), which otherwise depend on host proteinaceous components for growth. These include β-hexosaminidases (Roy et al., 2012) and most prominently sialidases (Braham and Moncla, 1992; Ishikura et al., 2003; Honma et al., 2011; Roy et al., 2011; Kurniyati et al., 2013) which appears to play a role in colonization and pathogenesis. We speculate that sialidases of periodontal bacteria could likely be involved in immune regulation as well, as is the case with the pneumococcal sialidase which can potentially induce leukocytes to release proinflammatory cytokines through relieving the dampening effect of Siglec receptors (Chang et al., 2012). Siglecs are sialic acid binding lectins on immune cells. Their activation by cognate sialoconjugates causes recruitment of phosphatases to the ITIM domain (immunoreceptor tyrosine-based inhibitory motif), leading to the inhibition of kinase-dependent activation of inflammatory signaling cascade in the cell (Crocker et al., 2007). Thus, hydrolysis of sialic acid from Siglec ligands by bacterial sialidases can potentially mitigate the immunosuppressive activity of Siglecs. Alternatively, sialidases may provide sialic acid to periodontal bacteria for incorporation into their cell-surface components, affording them the ability to undermine immune system in different ways. In P. gingivalis, a recent study demonstrated that bacterial sialidases play important roles in capsule formation and resistance to complement attack (Li et al., 2012).

GLYCOMIMICRY

Evading immune recognition is critical for pathogen survival in the host. Pathogens decorate their surfaces with molecular structures that can mimic host molecules to avoid detection by the immune system. For example, hyaluronic acid and α2–8-linked sialic acid polymers are abundant on capsule polysaccharides of group-A streptococci (GAS) and group-B streptococci (GBS). These structures resemble glycosaminoglycan and glycosylated proteins present on host connective, epithelial and neural tissues respectively. The GBS-expressed polysaccharide mimics a unique glycan structure found in human glycoproteins recognized by Siglecs, coopting of which by bacterial polysaccharide can lead to dampening of the immune responses including the impairment of neutrophil attack. Likewise, polysaccharides of Neisseria meningitidis and Escherichia coli K1 antigens are structurally similar to those of human fetal neuronal cells (Finne et al., 1987; Robbins et al., 2011). It was also demonstrated that this microbial glycomimicry can mislead the host immune system. For instance, carbohydrate mimicry between C. jejuni lipooligosaccharide and gangliosides has been implicated in the onset of paralytic disorder Guillain–Barré syndrome. In this setting, infection by C. jejuni in humans is believed to induce cross-reactive serum antibodies which bind to and damage peripheral nerves resulting in autoimmune disorders (Yuki et al., 2004). Interestingly, T. forsythia terminal sugar pseudaminic acid linked to an O-glycan core at least partially mimics sialic acid structures. Therefore, it is tempting to speculate that by abundantly decorating the surface with modified pseudaminic acid residues the bacterium could avoid immune surveillance and enhance its survival.

CONCLUSION

This review highlights the range and potential for immunomodulation by surface protein glycans in several periodontal bacteria. We also highlight the action of an exemplar glycan, namely that on the Tannerella S-layer that influences immune responses and promotes survival and persistence in the body while promoting bone loss orally. We hypothesize that bacterial glycans might have a prominent role in influencing local and systemic immunity to affect the persistence and pathogenicity of pathogenic oral communities in periodontal disease. Therefore, the future targeting of such interactions may provide a novel approach for modulating periodontitis.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

The work performed in authors’ laboratories was supported by a grant (DE014749 to Ashu Sharma) from the National Institute of Dental and Craniofacial Research (Bethesda, MD) and by The Dunhill Medical Trust grant R185/0211 to Graham P. Stafford.

REFERENCES

  • Aruni A. W., Robles A., Fletcher H. M. (2013). VimA mediates multiple functions that control virulence in Porphyromonas gingivalis. Mol. Oral Microbiol. 28 167–180. doi: 10.1111/omi.12017. [PMC free article] [PubMed] [Cross Ref]
  • Ashline D., Singh S., Hanneman A., Reinhold V. (2005). Congruent strategies for carbohydrate sequencing. 1. Mining structural details by MSn. Anal. Chem. 77 6250–6262. doi: 10.1021/ac050724z. [PMC free article] [PubMed] [Cross Ref]
  • Avci F. Y., Kasper D. L. (2010). How bacterial carbohydrates influence the adaptive immune system. Annu. Rev. Immunol. 28 107–130. doi: 10.1146/annurev-immunol-030409-101159. [PubMed] [Cross Ref]
  • Avci F. Y., Li X., Tsuji M., Kasper D. L. (2013). Carbohydrates and T cells: a sweet twosome. Semin. Immunol. 25 146–151. doi: 10.1016/j.smim.2013.05.005. [PMC free article] [PubMed] [Cross Ref]
  • Beck J. D., Couper D. J., Falkner K. L., Graham S. P., Grossi S. G., Gunsolley J. C., et al. (2008). The Periodontitis and Vascular Events (PAVE) pilot study: adverse events. J. Periodontol. 79 90–96. doi: 10.1902/jop.2008.070223. [PubMed] [Cross Ref]
  • Braham P. H., Moncla B. J. (1992). Rapid presumptive identification and further characterization of Bacteroides forsythus. J. Clin. Microbiol. 30 649–654. [PMC free article] [PubMed]
  • Brisson J. R., Vinogradov E., Mcnally D. J., Khieu N. H., Schoenhofen I. C., Logan S. M., et al. (2010). The application of NMR spectroscopy to functional glycomics. Methods Mol. Biol. 600 155–173. doi: 10.1007/978-1-60761-454-8_11. [PubMed] [Cross Ref]
  • Chang Y. C., Uchiyama S., Varki A., Nizet V. (2012). Leukocyte inflammatory responses provoked by pneumococcal sialidase. MBio 3, pii: e00220–e00211. doi: 10.1128/mBio.00220-11. [PMC free article] [PubMed] [Cross Ref]
  • Chauhan J. S., Bhat A. H., Raghava G. P., Rao A. (2012). GlycoPP: a webserver for prediction of N- and O-glycosites in prokaryotic protein sequences. PLoS ONE 7:e40155. doi: 10.1371/journal.pone.0040155. [PMC free article] [PubMed] [Cross Ref]
  • Coyne M. J., Fletcher C. M., Chatzidaki-Livanis M., Posch G., Schaffer C., Comstock L. E. (2013). Phylum-wide general protein O-glycosylation system of the Bacteroidetes. Mol. Microbiol. 88 772–783. doi: 10.1111/mmi.12220. [PMC free article] [PubMed] [Cross Ref]
  • Crocker P. R., Paulson J. C., Varki A. (2007). Siglecs and their roles in the immune system. Nat. Rev. Immunol. 7 255–266. doi: 10.1038/nri2056. [PubMed] [Cross Ref]
  • Dewhirst F. E., Chen T., Izard J., Paster B. J., Tanner A. C., Yu W. H., et al. (2010). The human oral microbiome. J. Bacteriol. 192 5002–5017. doi: 10.1128/JB.00542-10. [PMC free article] [PubMed] [Cross Ref]
  • Eichler J. (2013). Extreme sweetness: protein glycosylation in archaea. Nat. Rev. Microbiol. 11 151–156. doi: 10.1038/nrmicro2957. [PubMed] [Cross Ref]
  • Finne J., Bitter-Suermann D., Goridis C., Finne U. (1987). An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues. J. Immunol. 138 4402–4407. [PubMed]
  • Fletcher C. M., Coyne M. J., Comstock L. E. (2011). Theoretical and experimental characterization of the scope of protein O-glycosylation in Bacteroides fragilis. J. Biol. Chem. 286 3219–3226. doi: 10.1074/jbc.M110.194506. [PubMed] [Cross Ref]
  • Fletcher C. M., Coyne M. J., Villa O. F., Chatzidaki-Livanis M., Comstock L. E. (2009). A general O-glycosylation system important to the physiology of a major human intestinal symbiont. Cell 137 321–331. doi: 10.1016/j.cell.2009.02.041. [PMC free article] [PubMed] [Cross Ref]
  • Geijtenbeek T. B., Den Dunnen J., Gringhuis S. I. (2009). Pathogen recognition by DC-SIGN shapes adaptive immunity. Future Microbiol. 4 879–890. doi: 10.2217/fmb.09.51. [PubMed] [Cross Ref]
  • Geijtenbeek T. B., Gringhuis S. I. (2009). Signalling through C-type lectin receptors: shaping immune responses. Nat. Rev. Immunol. 9 465–479. doi: 10.1038/nri2569. [PubMed] [Cross Ref]
  • Genco R. J. (2009). Periodontal disease and association with diabetes mellitus and diabetes: clinical implications. J. Dent. Hyg. 83 186–187. doi: 10.1902/annals.2001.6.1.99. [PubMed] [Cross Ref]
  • Genco R. J, Van Dyke T. E. (2010). Prevention: reducing the risk of CVD in patients with periodontitis. Nat. Rev. Cardiol. 7 479–480. doi: 10.1038/nrcardio.2010.120. [PubMed] [Cross Ref]
  • Glew M. D., Veith P. D., Peng B., Chen Y. Y., Gorasia D. G., Yang Q., et al. (2012). PG0026 is the C-terminal signal peptidase of a novel secretion system of Porphyromonas gingivalis. J. Biol. Chem. 287 24605–24617. doi: 10.1074/jbc.M112.369223. [PubMed] [Cross Ref]
  • Gomes-Filho I. S., Santos C. M., Cruz S. S., Passos Jde S., Cerqueira Ede M., Costa Mda C., et al. (2009). Periodontitis and nosocomial lower respiratory tract infection: preliminary findings. J. Clin. Periodontol. 36 380–387. doi: 10.1111/j.1600-051X.2009.01387.x. [PubMed] [Cross Ref]
  • Gonzalez-Fernandez A., Faro J., Fernandez C. (2008). Immune responses to polysaccharides: lessons from humans and mice. Vaccine 26 292–300. doi: 10.1016/j.vaccine.2007.11.042. [PubMed] [Cross Ref]
  • Guerry P., Ewing C. P., Schirm M., Lorenzo M., Kelly J., Pattarini D., et al. (2006). Changes in flagellin glycosylation affect Campylobacter autoagglutination and virulence. Mol. Microbiol. 60 299–311. doi: 10.1111/j.1365-2958.2006.05100.x. [PMC free article] [PubMed] [Cross Ref]
  • Guo Y., Nguyen K. A., Potempa J. (2010). Dichotomy of gingipains action as virulence factors: from cleaving substrates with the precision of a surgeon’s knife to a meat chopper-like brutal degradation of proteins. Periodontol. 2000 54 15–44. doi: 10.1111/j.1600-0757.2010.00377.x. [PMC free article] [PubMed] [Cross Ref]
  • Hitchen P., Brzostek J., Panico M., Butler J. A., Morris H. R., Dell A., et al. (2010). Modification of the Campylobacter jejuni flagellin glycan by the product of the Cj1295 homopolymeric-tract-containing gene. Microbiology 156 1953–1962. doi: 10.1099/mic.0.038091-0. [PMC free article] [PubMed] [Cross Ref]
  • Honma K., Inagaki S., Okuda K., Kuramitsu H. K., Sharma A. (2007). Role of a Tannerella forsythia exopolysaccharide synthesis operon in biofilm development. Microb. Pathog. 42 156–166. doi: 10.1016/j.micpath.2007.01.003. [PubMed] [Cross Ref]
  • Honma K., Mishima E., Sharma A. (2011). Role of Tannerella forsythia NanH sialidase in epithelial cell attachment. Infect. Immun. 79 393–401. doi: 10.1128/IAI.00629-10. [PMC free article] [PubMed] [Cross Ref]
  • Ishikura H., Arakawa S., Nakajima T., Tsuchida N., Ishikawa I. (2003). Cloning of the Tannerella forsythensis (Bacteroides forsythus) siaHI gene and purification of the sialidase enzyme. J. Med. Microbiol. 52 1101–1107. doi: 10.1099/jmm.0.05349-0. [PubMed] [Cross Ref]
  • Iwashkiw J. A., Seper A., Weber B. S., Scott N. E., Vinogradov E., Stratilo C., et al. (2012). Identification of a general O-linked protein glycosylation system in Acinetobacter baumannii and its role in virulence and biofilm formation. PLoS Pathog. 8:e1002758. doi: 10.1371/journal.ppat.1002758. [PMC free article] [PubMed] [Cross Ref]
  • Iwashkiw J. A., Vozza N. F., Kinsella R. L., Feldman M. F. (2013). Pour some sugar on it: the expanding world of bacterial protein O-linked glycosylation. Mol. Microbiol. 89 14–28. doi: 10.1111/mmi.12265. [PubMed] [Cross Ref]
  • Kandiba L., Eichler J. (2013). Analysis of putative nonulosonic acid biosynthesis pathways in Archaea reveals a complex evolutionary history. FEMS Microbiol. Lett. 345 110–120. doi: 10.1111/1574-6968.12193. [PubMed] [Cross Ref]
  • Karlyshev A. V., Everest P., Linton D., Cawthraw S., Newell D. G., Wren B. W. (2004). The Campylobacter jejuni general glycosylation system is important for attachment to human epithelial cells and in the colonization of chicks. Microbiology 150 1957–1964. doi: 10.1099/mic.0.26721-0. [PubMed] [Cross Ref]
  • Kishi M., Hasegawa Y., Nagano K., Nakamura H., Murakami Y., Yoshimura F. (2012). Identification and characterization of novel glycoproteins involved in growth and biofilm formation by Porphyromonas gingivalis. Mol. Oral Microbiol. 27 458–470. doi: 10.1111/j.2041-1014.2012.00659.x. [PubMed] [Cross Ref]
  • Kuo C., Takahashi N., Swanson A. F., Ozeki Y., Hakomori S. (1996). An N-linked high-mannose type oligosaccharide, expressed at the major outer membrane protein of Chlamydia trachomatis, mediates attachment and infectivity of the microorganism to HeLa cells. J. Clin. Invest. 98 2813–2818. doi: 10.1172/JCI119109. [PMC free article] [PubMed] [Cross Ref]
  • Kurniyati K., Zhang W., Zhang K., Li C. (2013). A surface-exposed neuraminidase affects complement resistance and virulence of the oral spirochete Treponema denticola. Mol. Microbiol. 89 842–856. doi: 10.1111/mmi.12311. [PubMed] [Cross Ref]
  • Lee S. W., Sabet M., Um H. S., Yang J., Kim H. C., Zhu W. (2006). Identification and characterization of the genes encoding a unique surface (S-) layer of Tannerella forsythia. Gene 371 102–111. doi: 10.1016/j.gene.2005.11.027. [PubMed] [Cross Ref]
  • Li C., Kurniyati Hu B., Bian J., Sun J., Zhang W., et al. (2012). Abrogation of neuraminidase reduces biofilm formation, capsule biosynthesis, and virulence of Porphyromonas gingivalis. Infect. Immun. 80 3–13. doi: 10.1128/IAI.05773-11. [PMC free article] [PubMed] [Cross Ref]
  • Macuch P. J., Tanner A. C. (2000). Campylobacter species in health, gingivitis, and periodontitis. J. Dent. Res. 79 785–792. doi: 10.1177/00220345000790021301. [PubMed] [Cross Ref]
  • Maue A. C., Mohawk K. L., Giles D. K., Poly F., Ewing C. P., Jiao Y., et al. (2012). The polysaccharide capsule of Campylobacter jejuni 81-176 modulates the host immune response. Infect. Immun. 81 665–672. doi: 10.1128/IAI.01008-12. [PMC free article] [PubMed] [Cross Ref]
  • Mazmanian S. K., Round J. L., Kasper D. L. (2008). A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453 620–625. doi: 10.1038/nature07008. [PubMed] [Cross Ref]
  • Meijerink M., Ferrando M. L., Lammers G., Taverne N., Smith H. E., Wells J. M. (2012). Immunomodulatory effects of Streptococcus suis capsule type on human dendritic cell responses, phagocytosis and intracellular survival. PLoS ONE 7:e35849. doi: 10.1371/journal.pone.0035849. [PMC free article] [PubMed] [Cross Ref]
  • Messner P., Steiner K., Zarschler K., Schaffer C. (2008). S-layer nanoglycobiology of bacteria. Carbohydr. Res. 343 1934–1951. doi: 10.1016/j.carres.2007.12.025. [PubMed] [Cross Ref]
  • Myneni S. R., Settem R. P., Connell T. D., Keegan A. D., Gaffen S. L., Sharma A. (2011). TLR2 signaling and Th2 responses drive Tannerella forsythia-induced periodontal bone loss. J. Immunol. 187 501–509. doi: 10.4049/jimmunol.1100683. [PMC free article] [PubMed] [Cross Ref]
  • Myneni S. R., Settem R. P., Sojar H. T., Malone J. P., Loimaranta V., Nakajima T., et al. (2012). Identification of a unique TLR2-interacting peptide motif in a microbial leucine-rich repeat protein. Biochem. Biophys. Res. Commun. 423 577–582. doi: 10.1016/j.bbrc.2012.06.008. [PMC free article] [PubMed] [Cross Ref]
  • Nothaft H., Szymanski C. M. (2010). Protein glycosylation in bacteria: sweeter than ever. Nat. Rev. Microbiol. 8 765–778. doi: 10.1038/nrmicro2383. [PubMed] [Cross Ref]
  • Ochoa-Reparaz J., Mielcarz D. W., Wang Y., Begum-Haque S., Dasgupta S., Kasper D. L., et al. (2010). A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease. Mucosal Immunol. 3 487–495. doi: 10.1038/mi.2010.29. [PubMed] [Cross Ref]
  • Onishi S., Honma K., Liang S., Stathopoulou P., Kinane D., Hajishengallis G., et al. (2008). Toll-like receptor 2-mediated interleukin-8 expression in gingival epithelial cells by the Tannerella forsythia leucine-rich repeat protein BspA. Infect. Immun. 76 198–205. doi: 10.1128/IAI.01139-07. [PMC free article] [PubMed] [Cross Ref]
  • Paramonov N., Rangarajan M., Hashim A., Gallagher A., Aduse-Opoku J., Slaney J. M., et al. (2005). Structural analysis of a novel anionic polysaccharide from Porphyromonas gingivalis strain W50 related to Arg-gingipain glycans. Mol. Microbiol. 58 847–863. doi: 10.1111/j.1365-2958.2005.04871.x. [PubMed] [Cross Ref]
  • Posch G., Pabst M., Brecker L., Altmann F., Messner P., Schaffer C. (2011). Characterization and scope of S-layer protein O-glycosylation in Tannerella forsythia. J. Biol. Chem. 286 38714–38724. doi: 10.1074/jbc.M111.284893. [PubMed] [Cross Ref]
  • Posch G., Pabst M., Neumann L., Coyne M. J., Altmann F., Messner P., et al. (2013). “Cross-glycosylation” of proteins in Bacteroidales species. Glycobiology 23 568–577. doi: 10.1093/glycob/cws172. [PMC free article] [PubMed] [Cross Ref]
  • Robbins J. B., Schneerson R., Xie G., Hanson L. A., Miller M. A. (2011). Capsular polysaccharide vaccine for Group B Neisseria meningitidis, Escherichia coli K1, and Pasteurella haemolytica A2. Proc. Natl. Acad. Sci. U.S.A. 108 17871–17875. doi: 10.1073/pnas.1114489108. [PubMed] [Cross Ref]
  • Roy S., Honma K., Douglas I., Sharma A., Stafford G. (2011). Role of sialidase in glycoprotein utilisation by Tannerella forsythia. Microbiology 157 3195–3202. doi: 10.1099/mic.0.052498-0. [PMC free article] [PubMed] [Cross Ref]
  • Roy S., Phansopa C., Stafford P., Honma K., Douglas C. W., Sharma A., et al. (2012). Beta-hexosaminidase activity of the oral pathogen Tannerella forsythia influences biofilm formation on glycoprotein substrates. FEMS Immunol. Med. Microbiol. 65 116–120. doi: 10.1111/j.1574-695X.2012.00933.x. [PubMed] [Cross Ref]
  • Sabet M., Lee S. W., Nauman R. K., Sims T., Um H. S. (2003). The surface (S-) layer is a virulence factor of Bacteroides forsythus. Microbiology 149 3617–3627. doi: 10.1099/mic.0.26535-0. [PubMed] [Cross Ref]
  • Sara M., Sleytr U. B. (2000). S-Layer proteins. J. Bacteriol. 182 859–868. doi: 10.1128/JB.182.4.859-868.2000. [PMC free article] [PubMed] [Cross Ref]
  • Scher J. U., Ubeda C., Equinda M., Khanin R., Buischi Y., Viale A., et al. (2012). Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis. Arthritis Rheum. 64 3083–3094. doi: 10.1002/art.34539. [PMC free article] [PubMed] [Cross Ref]
  • Settem R. P., Honma K., Nakajima T., Phansopa C., Roy S., Stafford G. P., et al. (2012). A bacterial glycan core linked to surface (S)-layer proteins modulates host immunity through Th17 suppression. Mucosal Immunol. 6 415–426. doi: 10.1038/mi.2012.85. [PubMed] [Cross Ref]
  • Sharma A. (2010). Virulence mechanisms of Tannerella forsythia. Periodontol. 2000 54 106–116. doi: 10.1111/j.1600-0757.2009.00332.x. [PMC free article] [PubMed] [Cross Ref]
  • Socransky S. S., Haffajee A. D., Cugini M. A., Smith C., Kent R. L. , Jr (1998). Microbial complexes in subgingival plaque. J. Clin. Periodontol. 25 134–144. doi: 10.1111/j.1600-051X.1998.tb02419.x. [PubMed] [Cross Ref]
  • Surana N. K., Kasper D. L. (2012). The yin yang of bacterial polysaccharides: lessons learned from B. fragilis PSA. Immunol. Rev. 245 13–26. doi: 10.1111/j.1600-065X.2011.01075.x. [PMC free article] [PubMed] [Cross Ref]
  • Szymanski C. M., Burr D. H., Guerry P. (2002). Campylobacter protein glycosylation affects host cell interactions. Infect. Immun. 70 2242–2244. doi: 10.1128/IAI.70.4.2242-2244.2002. [PMC free article] [PubMed] [Cross Ref]
  • Szymanski C. M., Wren B. W. (2005). Protein glycosylation in bacterial mucosal pathogens. Nat. Rev. Microbiol. 3 225–237. doi: 10.1038/nrmicro1100. [PubMed] [Cross Ref]
  • Takeuchi O., Akira S. (2010). Pattern recognition receptors and inflammation. Cell 140 805–820. doi: 10.1016/j.cell.2010.01.022. [PubMed] [Cross Ref]
  • Tzianabos A. O., Finberg R. W., Wang Y., Chan M., Onderdonk A. B., Jennings H. J., et al. (2000). T cells activated by zwitterionic molecules prevent abscesses induced by pathogenic bacteria. J. Biol. Chem. 275 6733–6740. doi: 10.1074/jbc.275.10.6733. [PubMed] [Cross Ref]
  • van den Berg L. M., Gringhuis S. I., Geijtenbeek T. B. (2012). An evolutionary perspective on C-type lectins in infection and immunity. Ann. N. Y. Acad. Sci. 1253 149–158. doi: 10.1111/j.1749-6632.2011.06392.x. [PubMed] [Cross Ref]
  • Vik A., Aas F. E., Anonsen J. H., Bilsborough S., Schneider A., Egge-Jacobsen W., et al. (2009). Broad spectrum O-linked protein glycosylation in the human pathogen Neisseria gonorrhoeae. Proc. Natl. Acad. Sci. U.S.A. 106 4447–4452. doi: 10.1073/pnas.0809504106. [PubMed] [Cross Ref]
  • Young K. T., Davis L. M., Dirita V. J. (2007). Campylobacter jejuni: molecular biology and pathogenesis. Nat. Rev. Microbiol. 5 665–679. doi: 10.1038/nrmicro1718. [PubMed] [Cross Ref]
  • Yuki N., Susuki K., Koga M., Nishimoto Y., Odaka M., Hirata K., et al. (2004). Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain–Barré syndrome. Proc. Natl. Acad. Sci. U.S.A. 101 11404–11409. doi: 10.1073/pnas.0402391101. [PubMed] [Cross Ref]
  • Zeituni A. E., Mccaig W., Scisci E., Thanassi D. G., Cutler C. W. (2010). The native 67-kilodalton minor fimbria of Porphyromonas gingivalis is a novel glycoprotein with DC-SIGN-targeting motifs. J. Bacteriol. 192 4103–4110. doi: 10.1128/JB.00275-10. [PMC free article] [PubMed] [Cross Ref]

Articles from Frontiers in Microbiology are provided here courtesy of Frontiers Media SA